Zhitong Finance App News, Wangshan Wangshui-B (02630.HK) issued an announcement. Recently, the Group's self-developed new drug simenafil hydrochloride tablets (trade name: Onvidia®, R&D code: TPN171) for treating erectile dysfunction (ED) indications have been officially accepted by the Hong Kong Department of Health; the NDA of the Macau Special Administrative Region of China was also officially accepted by the Hong Kong Department of Health; the NDA of the Macau Special Administrative Region of China was also officially accepted by the Drug Administration on September 30, 2026.
Zhitongcaijing · 2d ago
Share
Listen to the news
Zhitong Finance App News, Wangshan Wangshui-B (02630.HK) issued an announcement. Recently, the Group's self-developed new drug simenafil hydrochloride tablets (trade name: Onvidia®, R&D code: TPN171) for treating erectile dysfunction (ED) indications have been officially accepted by the Hong Kong Department of Health; the NDA of the Macau Special Administrative Region of China was also officially accepted by the Hong Kong Department of Health; the NDA of the Macau Special Administrative Region of China was also officially accepted by the Drug Administration on September 30, 2026.
Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.
What's Trending